Zeke Capital Advisors, LLC Viatris Inc Transaction History
Zeke Capital Advisors, LLC
- $1.53 Billion
- Q4 2022
A detailed history of Zeke Capital Advisors, LLC transactions in Viatris Inc stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 11,257 shares of VTRS stock, worth $126,641. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,257Holding current value
$126,641% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VTRS
# of Institutions
1,135Shares Held
987MCall Options Held
2.34MPut Options Held
2.21M-
Vanguard Group Inc Valley Forge, PA142MShares$1.6 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.04 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$717 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$704 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$660 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.6B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...